Skip to main content

Advertisement

Log in

Short-Term Effects of Relamorelin on Descending Colon Motility in Chronic Constipation: A Randomized, Controlled Trial

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Background

The pentapeptide ghrelin agonist, relamorelin, accelerates colonic transit in patients with chronic constipation (CC). In a murine model, relamorelin decreased excitability of colonic circular smooth muscle cells and colonic intraluminal pressure.

Aim

To determine short-term effects of relamorelin on colonic motility measured by barostat and multilumen manometry in CC.

Methods

In a placebo-controlled, single-dose, double-blind, randomized study in patients with CC, we investigated the motor effects of relamorelin, 100 μg, SQ (12 patients) compared to placebo SQ (six patients). A motility-barostat balloon assembly was used to measure colonic compliance; tone and phasic pressure activity were measured before and after a 1000-kcal milkshake meal (administered ~60 min post-medication). Overall “background” phasic pressure activity was assessed by: average amplitude and motility index (MI = ln[sum amplitudes × #contractions + 1]) over defined periods. High-amplitude propagating contractions (HAPCs) were characterized by amplitude >75 mmHg and propagating contractions >50 mmHg; both were propagated over at least 10 cm. Postprandial HAPCs were the primary end point. The study sample had 80 % power to detect an increase of 3.3 HAPCs in the hour post-meal.

Results

Relamorelin, 100 μg, significantly induced more pre-meal propagated contractions [PCs of either >50 or >75 mmHg] compared to placebo (p < 0.05). Relamorelin also induced more post-meal PCs >50 or >75 mmHg than placebo. Relamorelin did not significantly alter colonic compliance, fasting or postprandial phasic pressure activity (20 min pre-meal fasting MI) or tone, and 60 min postprandial phasic pressure amplitude or MI, or tone.

Conclusions

Relamorelin stimulates propagated colonic contractions without alteration of background irregular contractions in CC.

ClinicalTrial.Gov registration number: NCT 01781104.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. van der Lely AJ, Tschop M, Heiman ML, Ghigo E. Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocr Rev. 2004;25:426–457.

    Article  PubMed  Google Scholar 

  2. Trudel L, Tomasetto C, Rio MC, et al. Ghrelin/motilin-related peptide is a potent prokinetic to reverse gastric postoperative ileus in rat. Am J Physiol Gastrointest Liver Physiol. 2002;282:G948–G952.

    Article  CAS  PubMed  Google Scholar 

  3. Dass NB, Munonyara M, Bassil AK, et al. Growth hormone secretagogue receptors in rat and human gastrointestinal tract and the effects of ghrelin. Neuroscience. 2003;120:443–453.

    Article  CAS  PubMed  Google Scholar 

  4. Tack J, Depoortere I, Bisschops R, et al. Influence of ghrelin on interdigestive gastrointestinal motility in humans. Gut. 2006;55:327–333.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  5. Murray CD, Martin NM, Patterson M, et al. Ghrelin enhances gastric emptying in diabetic gastroparesis: a double blind, placebo controlled, crossover study. Gut. 2005;54:1693–1698.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  6. Camilleri M, Papathanasopoulos A, Odunsi S. Actions and therapeutic pathways of ghrelin for gastrointestinal disorders. Nat Rev Gastroenterol Hepatol. 2009;6:343–352.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  7. Camilleri M, Acosta A. Emerging treatments in neurogastroenterology: relamorelin: a novel gastrocolokinetic synthetic ghrelin agonist. Neurogastroenterol Motil. 2015;27:324–332.

    Article  CAS  PubMed  Google Scholar 

  8. Acosta A, Camilleri M, Kolar G, et al. Relamorelin relieves constipation and accelerates colonic transit in a phase 2, placebo-controlled, randomized trial. Clin Gastroenterol Hepatol 2015. doi:10.1016/j.cgh.2015.04.184.

  9. Singh S, Heady S, Coss-Adame E, Rao SS. Clinical utility of colonic manometry in slow transit constipation. Neurogastroenterol Motil. 2013;25:487–495.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  10. Dinning PG, Wiklendt L, Maslen L, et al. Colonic motor abnormalities in slow transit constipation defined by high resolution, fibre-optic manometry. Neurogastroenterol Motil. 2015;27:379–388.

    Article  CAS  PubMed  Google Scholar 

  11. Date Y, Kojima M, Hosoda H, et al. Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinol. 2000;141:4255–4261.

    CAS  Google Scholar 

  12. Sha L, Farrugia G, Van der Ploeg LHT, Szurszewski JH. Effect of RM-131 on circular smooth muscle cells in human and mouse colon and on colonic intraluminal pressure in conscious mice. Gastroenterology. 2014;146:S363.

    Article  Google Scholar 

  13. Avau B, Carbone F, Tack J, Depoortere I. Ghrelin signaling in the gut, its physiological properties, and therapeutic potential. Neurogastroenterol Motil. 2013;25:720–732.

    Article  CAS  PubMed  Google Scholar 

  14. Shimizu Y, Chang E, Shafton A, et al. Evidence that stimulation of ghrelin receptors in the spinal cord initiates propulsive activity in the colon of the rat. J Physiol. 2006;576:329–338.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  15. Law NM, Bharucha AE, Undale AS, Zinsmeister AR. Cholinergic stimulation enhances colonic motor activity, transit, and sensation in humans. Am J Physiol Gastrointest Liver Physiol. 2001;281:G1228–G1237.

    CAS  PubMed  Google Scholar 

  16. Preston DM, Lennard-Jones JE. Pelvic motility and response to intraluminal bisacodyl in slow-transit constipation. Dig Dis Sci. 1985;30:289–294.

    Article  CAS  PubMed  Google Scholar 

  17. Spiller RC, Brown ML, Phillips SF. Decreased fluid tolerance, accelerated transit, and abnormal motility of the human colon induced by oleic acid. Gastroenterology. 1986;91:100–107.

    CAS  PubMed  Google Scholar 

  18. Kamath PS, Phillips SF, O’Connor MK, Brown ML, Zinsmeister AR. Colonic capacitance and transit in man: modulation by luminal contents and drugs. Gut. 1990;31:443–449.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  19. Szarka LA, Camilleri M. Methods for the assessment of small-bowel and colonic transit. Sem Nucl Med. 2012;42:113–123.

    Article  Google Scholar 

  20. Bharucha AE, Camilleri M, Zinsmeister AR, Hanson RB. Adrenergic modulation of human colonic motor and sensory function. Am J Physiol. 1997;273:G997–G1006.

    CAS  PubMed  Google Scholar 

  21. Ford MJ, Camilleri M, Zinsmeister AR, Hanson RB. Psychosensory modulation of colonic sensation in the human transverse and sigmoid colon. Gastroenterology. 1995;109:1772–1780.

    Article  CAS  PubMed  Google Scholar 

  22. Bharucha AE, Camilleri M, Haydock S, et al. Effects of a serotonin 5-HT(4) receptor antagonist SB-207266 on gastrointestinal motor and sensory function in humans. Gut. 2000;47:667–674.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  23. Chial HJ, Camilleri M, Ferber I, et al. Effects of venlafaxine, buspirone, and placebo on colonic sensorimotor functions in healthy humans. Clin Gastroenterol Hepatol. 2003;1:211–218.

    Article  CAS  PubMed  Google Scholar 

  24. Delgado-Aros S, Chial HJ, Camilleri M, et al. Effects of a kappa-opioid agonist, asimadoline, on satiation and GI motor and sensory functions in humans. Am J Physiol. 2003;284:G558–G566.

    CAS  Google Scholar 

  25. Odunsi ST, Camilleri M, Bharucha AE, et al. Reproducibility and performance characteristics of colonic compliance, tone, and sensory tests in healthy humans. Dig Dis Sci. 2010;55:709–715.

    Article  PubMed Central  PubMed  Google Scholar 

  26. Talley NJ, Phillips SF, Melton LJ 3rd, Wiltgen C, Zinsmeister AR. A patient questionnaire to identify bowel disease. Ann Intern Med. 1989;111:671–674.

    Article  CAS  PubMed  Google Scholar 

  27. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology. 2006;130:1480–1491.

    Article  PubMed  Google Scholar 

  28. Lembo A, Camilleri M. Chronic constipation. N Engl J Med. 2003;349:1360–1368.

    Article  CAS  PubMed  Google Scholar 

  29. Shin A, Camilleri M, Busciglio I, et al. The ghrelin agonist RM-131 accelerates gastric emptying of solids and reduces symptoms in patients with type 1 diabetes mellitus. Clin Gastroenterol Hepatol. 2013;11:1453–1459.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  30. Shin A, Camilleri M, Busciglio I, et al. Randomized controlled phase Ib study of ghrelin agonist, RM-131, in type 2 diabetic women with delayed gastric emptying: pharmacokinetics and pharmacodynamics. Diab Care. 2013;36:41–48.

    Article  CAS  Google Scholar 

  31. Lembo A, Camilleri M, McCallum R, et al. A phase 2, randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of RM-131 in patients with diabetic gastroparesis. Gastroenterology. 2014;146:S158–S159.

    Article  Google Scholar 

  32. Kaplan L, White J, Spence S, et al. RM-131, a novel ghrelin analog, demonstrates potent prokinetic activity in phase 1 single- and multiple-dose studies in healthy volunteers. Am J Gastroenterol. 2012;107:S706–S707.

    Article  Google Scholar 

  33. Van der Ploeg L, Laken H, Sharma S, et al. Preclinical gastrointestinal prokinetic efficacy and endocrine effects of the ghrelin mimetic RM-131. Life Sci. 2014;109:20–29.

    Article  PubMed  Google Scholar 

  34. Bassotti G, Crowell MD, Whitehead WE. Contractile activity of the human colon: lessons from 24 hour studies. Gut. 1993;34:129–133.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  35. Hagger R, Kumar D, Benson M, Grundy A. Colonic motor activity in slow-transit idiopathic constipation as identified by 24-h pancolonic ambulatory manometry. Neurogastroenterol Motil. 2003;15:515–522.

    Article  CAS  PubMed  Google Scholar 

  36. Floyd BN, Camilleri M, Andresen V, Esfandyari T, Busciglio I, Zinsmeister AR. Comparison of mathematical methods for calculating colonic compliance in humans: power exponential, computer-based and manual linear interpolation models. Neurogastroenterol Motil. 2008;20:330–335.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  37. O’Brien MD, Camilleri M, von der Ohe MR, et al. Motility and tone of the left colon in constipation: a role in clinical practice? Am J Gastroenterol. 1996;91:2532–2538.

    PubMed  Google Scholar 

  38. Choi MG, Camilleri M, O’Brien MD, Kammer PP, Hanson RB. A pilot study of motility and tone of the left colon in patients with diarrhea due to functional disorders and dysautonomia. Am J Gastroenterol. 1997;92:297–302.

    CAS  PubMed  Google Scholar 

  39. De Schryver AM, Andriesse GI, Samsom M, Smout AJ, Gooszen HG, Akkermans LM. The effects of the specific 5HT(4) receptor agonist, prucalopride, on colonic motility in healthy volunteers. Aliment Pharmacol Ther. 2002;16:603–612.

    Article  PubMed  Google Scholar 

  40. Connell AM. The motility of the pelvic colon. II. Paradoxical motility in diarrhoea and constipation. Gut. 1962;3:342–348.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  41. Rodriguez L, Siddiqui A, Nurko S. Internal anal sphincter relaxation associated with bisacodyl induced colonic high amplitude propagating contractions in children with constipation: A colo anal reflex? Neurogastroenterol Motil. 2012;24:1023-e545.

    PubMed Central  PubMed  Google Scholar 

  42. Bampton PA, Dinning PG, Kennedy ML, Lubowski DZ, Cook IJ. The proximal colonic motor response to rectal mechanical and chemical stimulation. Am J Physiol Gastrointest Liver Physiol. 2002;282:G443–G449.

    Article  CAS  PubMed  Google Scholar 

  43. Leelakusolvong S, Bharucha AE, Sarr MG, Hammond PI, Brimijoin S, Phillips SF. Effect of extrinsic denervation on muscarinic neurotransmission in the canine ileocolonic region. Neurogastroenterol Motil. 2003;15:173–186.

    Article  CAS  PubMed  Google Scholar 

  44. Bharucha AE. High amplitude propagated contractions. Neurogastroenterol Motil. 2012;24:977–982.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  45. Halder SL, Locke GR 3rd, Schleck CD, Zinsmeister AR, Melton LJ 3rd, Talley NJ. Natural history of functional gastrointestinal disorders: a 12-year longitudinal population-based study. Gastroenterology. 2007;133:799–807.

    Article  PubMed  Google Scholar 

  46. Ravi K, Bharucha AE, Camilleri M, Rhoten D, Bakken T, Zinsmeister AR. Phenotypic variation of colonic motor functions in chronic constipation. Gastroenterology. 2010;138:89–97.

    Article  PubMed Central  PubMed  Google Scholar 

  47. Kolar GJ, Camilleri M, Burton D, Nadeau A, Zinsmeister AR. Prevalence of colonic motor or evacuation disorders in patients presenting with chronic nausea and vomiting evaluated by a single gastroenterologist in a tertiary referral practice. Neurogastroenterol Motil. 2014;26:131–138.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The authors thank Mrs. Cindy Stanislav for excellent secretarial assistance.

Funding

Rhythm Pharmaceuticals provided medication and a grant to cover part of the cost of this research study, which was otherwise funded by Mayo Clinic. Dr. M. Camilleri’s research on colonic motility is supported in part by NIH R01-DK92179.

Author contributions

Andres Acosta is a fellow co-investigator and co-author and contributed toward screening of patients. Michael Camilleri is the principal investigator, helped with endoscopy and placement of colonic device, and author of manuscript. Amy Boldingh is the study coordinator and recruited participants. Irene Busciglio is the colonic motility technician and analyzed data. Alfred D. Nelson is a fellow co-investigator and co-author and contributed toward screening of patients. Duane Burton is the laboratory supervisor and analyzed data.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Michael Camilleri.

Ethics declarations

Conflict of interest

Dr. Camilleri serves on the advisory board of Rhythm Pharmaceuticals with payment for his services to his employer, Mayo Clinic. The other authors have no conflicts of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Acosta, A., Camilleri, M., Busciglio, I. et al. Short-Term Effects of Relamorelin on Descending Colon Motility in Chronic Constipation: A Randomized, Controlled Trial. Dig Dis Sci 61, 852–860 (2016). https://doi.org/10.1007/s10620-015-3876-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-015-3876-5

Keywords

Navigation